Monte Rosa Therapeutics
GLUE
GLUE
81 hedge funds and large institutions have $264M invested in Monte Rosa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+7
Holders Change %
+9.46%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
41
Reduced
11
Closed
7
Calls
$895K
Puts
$165K
Net Calls
+$730K
Net Calls Change
+$445K
Top Buyers
| 1 |
ACA
1
Avoro Capital Advisors
New York
|
$30.7M |
| 2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$35M |
| 3 |
3
BlackRock
New York
|
$15.4M |
| 4 |
PL
4
Parkwood LLC
Cleveland,
Ohio
|
$2.26M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$1.65M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1.59K | – | – | – |
|
|
SCM
77
Sterling Capital Management
Charlotte,
North Carolina
| $779 | +$779 | +147 | New |
|
|
GI
78
GAMMA Investing
Foster City,
California
| $292 | +$16 | +3 | +6% |
|
|
CPA
79
Capital Performance Advisors
Walnut Creek,
California
| $154 | +$154 | +29 | New |
|
80
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $148 | – | – | – |
|
|
SP
81
Sarasin & Partners
London,
United Kingdom
| – | -$243K | -65,081 | Closed |
|
|
GCP
82
GSA Capital Partners
London,
United Kingdom
| – | -$95K | -25,346 | Closed |
|
83
Squarepoint
New York
| – | -$84.8K | -22,665 | Closed |
|
|
CP
84
Castleview Partners
Dallas,
Texas
| – | -$70.9K | -18,950 | Closed |
|
85
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$62K | -16,566 | Closed |
|
|
JF
86
Jump Financial
Chicago,
Illinois
| – | -$61.1K | -16,338 | Closed |
|
87
Russell Investments Group
London,
United Kingdom
| – | -$9.84K | -2,631 | Closed |
|